Increased risk of psoriasis following obstructive sleep apnea: A longitudinal population-based study

Sleep Medicine

Volumn 13, Issue 3, 2012, Pages 285-289

  Yang, Ya Wen ^a,b   Kang, Jiunn Horng ^a   Lin, Herng Ching ^c  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Epidemiology; Inflammation; Obstructive sleep apnea; OSA; Psoriasis; Psoriatic arthritis

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GEOGRAPHY; HUMAN; INCOME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; PSORIATIC ARTHRITIS; SLEEP APNEA SYNDROME; TAIWAN; URBANIZATION;

ADULT; ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INSURANCE, HEALTH; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PSORIASIS; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TAIWAN;

EID: 84862832544     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2011.07.018     Document Type: Article

References (32)

1. Guilleminault C., Tilkian A., Dement W.C. The sleep apnea syndromes. Annu Rev Med 1976, 27:465-484.
2. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
3. Bagai K. Obstructive sleep apnea, stroke, and cardiovascular diseases. Neurologist 2010, 16:329-339.
4. Tasali E., Mokhlesi B., Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008, 133:496-506.
5. Ip M.S., Lam B., Ng M.M., Lam W.K., Tsang K.W., Lam K.S. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165:670-676.
6. Hatipoglu U., Rubinstein I. Inflammation and obstructive sleep apnea syndrome: how many ways do I look at thee?. Chest 2004, 126:1-2.
7. Guardiola J.J., Matheson P.J., Clavijo L.C., Wilson M.A., Fletcher E.C. Hypercoagulability in patients with obstructive sleep apnea. Sleep Med 2001, 2:517-523.
8. Selmi C., Montano N., Furlan R., Keen C.L., Gershwin M.E. Inflammation and oxidative stress in obstructive sleep apnea syndrome. Exp Biol Med (Maywood) 2007, 232:1409-1413.
9. Sanders M.H. Elevated plasma C-reactive protein and increased cardiovascular/cerebrovascular risk in sleep apnea patients. Article reviewed: elevated C-reactive protein in patients with obstructive sleep apnea (a brief rapid communication). Sleep Med 2002, 3:449-450.
10. Gudjonsson JE, Elder JT. "Chapter 18. Psoriasis" (Chapter). In: Goldsmith L, Wolff K, Katz SI, Gilchrest B, Paller AS, Leffell DJ, editors. Fitzpatrick's dermatology in general medicine, 7e: http://www.accessmedicine.com/contentaspx?aID=2983780.
11. Gelfand J.M., Gladman D.D., Mease P.J., et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005, 53:573.
12. Rapp S.R., Feldman S.R., Exum M.L., Fleischer A.B., Reboussin D.M. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999, 41:401-407.
13. Sampogna F., Tabolli S., Soderfeldt B., Axtelius B., Aparo U., Abeni D. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol 2006, 154:844-849.
14. Smith C.H., Anstey A.V., Barker J.N., Burden A.D., Chalmers R.J., Chandler D.A., et al. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 2009, 161:987-1019.
15. Chen Y.H., Lin H.C. Increased risk of cancer subsequent to severe depression-A nationwide population-based study. J Affect Disord 2011, 131:200-206.
16. Ryan S., Taylor C.T., McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005, 112:2660-2667.
17. Nanduri J., Yuan G., Kumar G.K., Semenza G.L., Prabhakar N.R. Transcriptional responses to intermittent hypoxia. Respir Physiol Neurobiol 2008, 164:277-281.
18. Minoguchi K., Tazaki T., Yokoe T., Minoguchi H., Watanabe Y., Yamamoto M., et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004, 126:1473-1479.
19. Yokoe T., Minoguchi K., Matsuo H., Oda N., Minoguchi H., Yoshino G., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003, 107:1129-1134.
20. Ryan S., Taylor C.T., McNicholas W.T. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006, 174:824-830.
21. Willerson J.T., Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 2004, 109:II2-II10.
22. Sjoholm A., Nystrom T. Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev 2006, 22:4-10.
23. Schon M.P., Boehncke W.H. Psoriasis. N Engl J Med 2005, 352:1899-1912.
24. Bonifati C., Carducci M., Cordiali Fei P., Trento E., Sacerdoti G., Fazio M., et al. Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients-relationships with disease severity. Clin Exp Dermatol 1994, 19:383-387.
25. Arican O., Aral M., Sasmaz S., Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005, 2005:273-279.
26. Imagawa S., Yamaguchi Y., Higuchi M., Neichi T., Hasegawa Y., Mukai H.Y., et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 2001, 98:1255-1257.
27. Lavie L., Kraiczi H., Hefetz A., Ghandour H., Perelman A., Hedner J., et al. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 2002, 165:1624-1628.
28. Rosenberger C., Solovan C., Rosenberger A.D., Jinping L., Treudler R., Frei U., et al. Upregulation of hypoxia-inducible factors in normal and psoriatic skin. J Invest Dermatol 2007, 127:2445-2452.
29. Yip S.Y. The prevalence of psoriasis in the Mongoloid race. J Am Acad Dermatol 1984, 10:965-968.
30. Raychaudhuri S.P., Farber E.M. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 2001, 15:16-17.
31. Husted J.A., Gladman D.D., Farewell V.T., Cook R.J. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001, 45:151-158.
32. D'Ambrosio C., Bowman T., Mohsenin V. Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure - A prospective study. Chest 1999, 115:123-129.